Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medical Devices
Safety Information
Safety communications
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
COVID-19 Updates
Our role
Safety Information
Reporting safety issues
Monitoring device safety
Safety communications
About HPRA Safety Notices
Manufacturer's Field Safety Notices
User Engagement
Consumer advice
Regulatory Information
Registration
Medical Devices News & Events
Special Topics
Contact Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Omnifuse and Omnifuse PCA Syringe Pumps
Notice type:
Advisory
Date:
07/02/2012
Product name or type:
Omnifuse and Omnifuse PCA Syringe Pumps
Reference:
SN2012(01)
Manufacturer Or Supplier:
Smiths Medical International
Target Audience:
Hospital
Hospital CEOs
Hospital Risk Managers
Medical Nursing Staff
Paramedics
Palliative Care Units
Intensive Care Units
Anaesthetic Officers
General Practitioners
Practice Nurses
Clinical Engineers
General Public
Hospices
Nursing Homes
Community Care Managers
Community Therapists
Carers
Problem Or Issue:
The Omnifuse and Omnifuse PCA Pumps may alarm and stop delivery of infusion due to significant vibration when transporting the pumps.
Background Information Or Related Documents:
In July 2011, Smiths Medical initiated a field safety corrective action to highlight the possible impact of significant vibration or jarring to Omnifuse and Omnifuse PCA Pumps in inducing a System Fault Code, causing the Pump to alarm and stop delivery of the infusion. This is due to the sensitivities of the precision accuracy detection mechanisms within the Omnifuse Pumps.
An example of the type of vibration or jarring that may induce a System Fault Code would be transporting a pump across an uneven surface (e.g., block paving). Smiths Medical has outlined recommendations for users of these devices to avoid this system error from occurring. The field safety notice associated with this issue is attached with this safety notice.
The manufacturer has notified the Irish Medicines Board (IMB) that despite their best efforts they have not managed to receive 100% reconciliation for acknowledgements of receipt of the field safety notice from customers in the Irish market. The IMB is issuing this safety notice to ensure all users of these devices are aware of this issue and to request that customers, upon receipt of the field safety notice, will confirm with the manufacturer that they are aware of the issue.
Omnifuse and Omnifuse PCA Syringe Pumps Document
Actions To Be Taken:
1. Ensure that the relevant personnel in your organisation are made aware of this issue.
2. Follow the recommendations as outlined by the manufacturer in the field
safety notice attached and confirm acknowledgement of receipt of the field
safety notice to the manufacturer.
3. If you have any concerns or queries relating to this issue please contact the
manufacturer using the contact details below.
Further Information:
All adverse incidents relating to a medical device should be reported to the:
Health Products Regulatory Authority
Kevin O’Malley House
Earlsfort Centre
Earlsfort Terrace
Dublin 2
Telephone: +353-1-6764971
Fax: +353-1-6344033
E-mail:
devicesafety@hpra.ie
Website:
www.hpra.ie
Enquiries to the manufacturer should be addressed to:
Manufacturer:
Smiths Medical International Ltd
.
Bramingham Business Park,
Enterprise Way,
Luton,
LU3 4BU,
United Kingdom.
Telephone: +44 (0)1582 430307 ext. 4770307
E-mail:
Mick.Boydon@smiths-medical.com
Please click here to download a PDF version of this Safety Notice
Please click here to download a PDF version of the field safety notice
« Back
Date Printed: 25/04/2024